We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.52%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$35.4B
AUM Growth
-$24.1M
(-0.07%)
Cap. Flow
+$1.61B
Cap. Flow
% of AUM
4.55%
Top 10 Holdings %
Top 10 Hldgs %
22.79%
Holding
788
New
213
Increased
159
Reduced
183
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.05B |
| 2 |
Micron Technology
MU
|
+$783M |
| 3 |
Robinhood
HOOD
|
+$698M |
| 4 |
GPGI
GPGI Inc
GPGI
|
+$453M |
| 5 |
Uber
UBER
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.4B |
| 2 |
Boeing
BA
|
+$512M |
| 3 |
Amazon
AMZN
|
+$432M |
| 4 |
DoorDash
DASH
|
+$372M |
| 5 |
Microsoft
MSFT
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.29% |
| 2 | Consumer Discretionary | 14.55% |
| 3 | Industrials | 12.02% |
| 4 | Healthcare | 11.78% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Aligos Therapeutics
ALGS
$26.2M
| $3.06M | 0.01% |
412,000
| – | – |
|
|
MAZE
527
Maze Therapeutics
MAZE
$1.49B
| $2.98M | 0.01% |
100,000
-96,124
| -49% | -$4.24M |
|
528
Joby Aviation
JOBY
$7.03B
| $2.92M | 0.01% |
353,427
+253,231
| +253% | +$2.85M |
|
529
Rhythm Pharmaceuticals
RYTM
$6.81B
| $2.83M | 0.01% |
+32,589
| New | +$3.17M |
|
|
FLG
530
Flagstar Bank National Association
FLG
$5.93B
| $2.8M | 0.01% |
212,778
-4,014,075
| -95% | -$52.6M |
|
531
Larimar Therapeutics
LRMR
$397M
| $2.78M | 0.01% |
617,211
-310,610
| -33% | -$1.24M |
|
|
IMDX
532
Insight Molecular Diagnostics
IMDX
$150M
| $2.76M | 0.01% |
+840,777
| New | +$4.88M |
|
533
Antero Resources
AR
$11.1B
| $2.74M | 0.01% |
64,513
-1,419,773
| -96% | -$51.8M |
|
|
EPRX
534
Eupraxia Pharmaceuticals
EPRX
$418M
| $2.71M | 0.01% |
+375,000
| New | +$3.02M |
|
|
UPB
535
Upstream Bio Inc
UPB
$343M
| $2.68M | 0.01% |
298,329
| – | – |
|
|
INN
536
Summit Hotel Properties
INN
$746M
| $2.65M | 0.01% |
598,819
| – | – |
|
|
BRR
537
ProCap Financial Inc
BRR
$154M
| $2.64M | 0.01% |
+1,250,000
| New | +$3.47M |
|
|
BETA
538
Beta Technologies Inc
BETA
$4.37B
| $2.61M | 0.01% |
177,867
| – | – |
|
|
ROC
539
Rank One Computing Corp
ROC
$84.3M
| $2.45M | 0.01% |
+350,000
| New | +$2.24M |
|
540
Comstock
LODE
$208M
| $2.23M | 0.01% |
+732,739
| New | +$2.4M |
|
541
Veru
VERU
$36M
| $2.21M | 0.01% |
1,000,000
| – | – |
|
|
CCXIU
542
Churchill Capital Corp XI Units
CCXIU
$427M
| $2.19M | 0.01% |
213,900
-1,286,100
| -86% | -$13.2M |
|
543
Phillips Edison & Co
PECO
$5.46B
| $2.14M | 0.01% |
57,297
-488,104
| -89% | -$18.1M |
|
|
ACOG
544
Alpha Cognition
ACOG
$180M
| $2M | 0.01% |
365,000
| – | – |
|
|
AMBQ
545
Ambiq Micro
AMBQ
$1.54B
| $1.99M | 0.01% |
78,305
+45,473
| +139% | +$1.36M |
|
|
AII
546
American Integrity Insurance
AII
$397M
| $1.99M | 0.01% |
103,188
-224,217
| -68% | -$4.27M |
|
547
Chubb
CB
$135B
| $1.99M | 0.01% |
+6,099
| New | +$1.96M |
|
|
CDNL
548
Cardinal Infrastructure Group
CDNL
$1.23B
| $1.98M | 0.01% |
50,000
-225,000
| -82% | -$6.52M |
|
549
Sabra Healthcare REIT
SBRA
$5.34B
| $1.9M | 0.01% |
+98,974
| New | +$1.95M |
|
550
Protara Therapeutics
TARA
$220M
| $1.82M | 0.01% |
350,000
| – | – |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2026 Portfolio in Review
As of Q1 2026, Alyeska Investment Group held 788 positions worth $35.4B, down 0.07% from $35.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Alyeska Investment Group deployed $1.61B of net new capital in Q1 2026, opening 213 new positions and adding to 159 existing holdings. Its largest new stake was NVIDIA: 5,697,978 shares worth $994M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.4B trimmed.
- Alyeska Investment Group's largest Q1 2026 buy was NVIDIA: 5,697,978 shares worth $994M.
- Alyeska Investment Group added most to GPGI Inc in Q1 2026, an estimated $453M increase.
- Alyeska Investment Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.4B.
- Alyeska Investment Group fully exited DoorDash in Q1 2026, selling an estimated $372M.
- Alyeska Investment Group's ten largest holdings make up 23% of its $35.4B portfolio in Q1 2026.
- Alyeska Investment Group opened 213 new positions and closed 183 in Q1 2026.
- Alyeska Investment Group's portfolio value fell 0.07% quarter-over-quarter to $35.4B.
Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.